Public Workshop on Antibacterial Resistance and Drug Development Research Announced

Article

The Food and Drug Administration, the National Institute of Allergy and Infectious Diseases (NIAID) and the Infectious Diseases Society of America (IDSA) will host a two-day workshop to bring together experts to discuss the scientific data addressing key issues in the science and mechanisms of bacterial resistance as well as the science of antibacterial drug development.

The Food and Drug Administration, the National Institute of Allergy and Infectious Diseases (NIAID) and the Infectious Diseases Society of America (IDSA) will host a two-day workshop to bring together experts to discuss the scientific data addressing key issues in the following areas:

-- Scale of the current bacterial resistance problem including extent, trajectory, and cost

-- Science and mechanisms of bacterial resistance

-- Science of development of rapid diagnostic devices

-- Science of antibacterial drug development

The event will be held July 26-27 at the Crowne Plaza Hotel in Silver Spring, Md. Registration is free for the public workshop. Interested parties are encouraged to register early because space is limited. Seating will be available on a first-come, first-served basis. To register electronically, email registration information (including name, title, firm name, address, telephone, and fax number) to arworkshop@fda.hhs.gov.

The workshop will be simultaneously web-cast. The public may view the live webcast free by pre-registering below until 24 hours prior to the workshop. IDSA will do its best to accommodate members of the public who register after this time.

For more details and to register, CLICK HERE.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.